NHI pricing on first and late coming products to differentiate.

Published: 2002-04-11 07:00:00

Updated: 2002-04-11 07:00:00

A research paper pointed out that the NHI prices for the late coming products should be differentiated from the first one, and the NHI drug listing should be periodically reviewed. For the reference price system, the reference pricing group has to be determined by active ingredients and the medic...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK